First published online March 22, 2006
Journal of Cell Science 119, 701e (2006)
© The Company of Biologists Limited
Signalling cystic fibrosis severity
Cystic fibrosis (CF), which affects the lungs and epithelia from other tissues, is caused by mutations in the cyclic-AMP-activated Cl- channel CFTR. The severity of the disease, however, varies widely between patients with the same CFTR mutation and must therefore be influenced by additional factors. On p. 1320, Stephen Shears and colleagues identify ITPK1, a kinase that produces the signalling molecule inositol 3,4,5,6-tetrakisphosphate [Ins(3,4,5,6)P4], as a potential modifier. Using an airway-epithelial-cell model, the authors show that Ins(3,4,5,6)P4 inhibits Ca2+-dependent Cl- secretion - this is upregulated in CF and partly compensates for the CFTR defect. They also show that Ins(3,4,5,6)P4 levels are reduced in murine tracheal CF epithelial (MTE) cells because of reduced expression of ITPK1. Furthermore, they note that ITPK1 is localized at the apical membrane of MTE cells, close to the Ca2+-dependent Cl- channels that its product inhibits. The authors suggest, therefore, that variability in ITPK1 expression may contribute to CF severity by affecting how well the Ca2+-dependent Cl- channels compensate for loss of CFTR.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
Related articles in JCS:
- Apical localization of ITPK1 enhances its ability to be a modifier gene product in a murine tracheal cell model of cystic fibrosis
- Ling Yang, Jeff Reece, Sherif E. Gabriel, and Stephen B. Shears
JCS 2006 119: 1320-1328.
[Abstract]
[Full Text]